Navigation Links
Glaucoma May Boost Cardiovascular Death Risk in Blacks

Inappropriate treatment with beta blockers, other meds also increases odds, study finds

TUESDAY, March 11 (HealthDay News) -- Black people diagnosed and treated for glaucoma and those with high pressure in their eyes may be at increased risk for cardiovascular death, a new study suggests.

"Glaucoma is one of the leading causes of visual impairment worldwide," the researchers from Stony Brook University in Stony Brook, N.Y., wrote as background information in the study. "The most common type, primary open-angle glaucoma, is especially prevalent in populations of African origin, in which it is the foremost cause of blindness."

In addition to higher rates of open-angle glaucoma, blacks also tend to have higher rates of high pressure in their eyes (ocular hypertension) and higher rates of death from chronic disease than whites, the study authors noted.

They analyzed data on 4,092 people, aged 40 to 84 (average age 58.6), who took part in the Barbados Eye Studies of a predominately black population with similar ancestry to black Americans.

During the initial study visits that took place between 1987 and 1992, participants' height, weight and blood pressure were recorded, they were interviewed, and various eye measurements -- including photos of the retina and eye pressure assessments -- were taken.

At the start of the study, 300 participants had glaucoma, including 141 who'd been diagnosed and treated. After nine years of follow-up, 764 (19 percent) of the participants had died.

After the researchers adjusted for other factors, they concluded that glaucoma was not associated with risk of death overall. However, they did find that the risk of cardiovascular death was: 28 percent higher in those with ocular hypertension at the start of the study; 38 percent higher in people who'd previously been diagnosed with or treated for open angle glaucoma; and 91 percent higher in those who'd been treated with a beta blocker drug called timolol maleate.

The findings were published in the March issue of the Archives of Ophthalmology.

"One explanation for the excess mortality [death] found in persons with previously diagnosed open-angle glaucoma could be their longer duration of disease compared with those with newly diagnosed disease," the study authors wrote. "Another explanation for an increased mortality risk could be related to the open-angle glaucoma treatment received."

They noted that inappropriate use, or adverse effects, of beta blockers and other medications used to treat glaucoma may damage the cardiovascular system. They also said there's some evidence that risk factors for ocular hypertension and cardiovascular disease are similar.

"These findings underscore the importance of close monitoring and controlling of adequate intraocular pressure levels in this and other high-risk populations," the researchers concluded.

More information

The U.S. National Eye Institute has more about glaucoma.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, March 10, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
2. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
3. Upcoming meeting will explore new technologies for glaucoma clinical drug trials
4. January is National Glaucoma Awareness Month
5. Cost of glaucoma medications may impact treatment
6. Looking at Glaucoma as a Systemic Disease
7. Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
8. Glaucoma surgery in the blink of an eye
9. Glaucoma surgery in the blink of an eye
10. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
11. New Method Boosts Cardiac Arrest Survival
Post Your Comments:
Related Image:
Glaucoma May Boost Cardiovascular Death Risk in Blacks
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: